{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:36:44Z","timestamp":1790984204837,"version":"4.1.0"},"reference-count":261,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41581-024-00901-6","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:02:06Z","timestamp":1730822526000},"page":"127-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Kidney disease and reproductive health"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3725-9879","authenticated-orcid":false,"given":"Priscilla A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippokratis","family":"Sarris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Wiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Bramham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"901_CR1","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 395, 709\u2013733 (2020)."},{"key":"901_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40620-018-00569-9","volume":"32","author":"SM Dumanski","year":"2019","unstructured":"Dumanski, S. M. & Ahmed, S. B. Fertility and reproductive care in chronic kidney disease. J. Nephrol. 32, 39\u201350 (2019).","journal-title":"J. Nephrol."},{"key":"901_CR3","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ki.2015.230","volume":"88","author":"KT Mills","year":"2015","unstructured":"Mills, K. T. et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 88, 950\u2013957 (2015).","journal-title":"Kidney Int."},{"key":"901_CR4","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.2337\/dci21-0027","volume":"45","author":"DS Feig","year":"2022","unstructured":"Feig, D. S. Epidemiology and therapeutic strategies for women with preexisting diabetes in pregnancy: how far have we come? The 2021 Norbert Freinkel Award Lecture. Diabetes Care 45, 2484\u20132491 (2022).","journal-title":"Diabetes Care"},{"key":"901_CR5","first-page":"1081","volume":"61","author":"ST Mackin","year":"2018","unstructured":"Mackin, S. T. et al. Diabetes and pregnancy: national trends over a 15 year period. Diabetologia 61, 1081\u20131088 (2018).","journal-title":"Diabetologia"},{"key":"901_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020717","volume":"10","author":"MC Wang","year":"2021","unstructured":"Wang, M. C. et al. Trends in prepregnancy obesity and association with adverse pregnancy outcomes in the United States, 2013 to 2018. J. Am. Heart Assoc. 10, e020717 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"901_CR7","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/s41430-021-00981-8","volume":"75","author":"A Strauss","year":"2021","unstructured":"Strauss, A. et al. Obesity in pregnant women: a 20-year analysis of the German experience. Eur. J. Clin. Nutr. 75, 1757\u20131763 (2021).","journal-title":"Eur. J. Clin. Nutr."},{"key":"901_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S2213-8587(16)30217-0","volume":"4","author":"L Poston","year":"2016","unstructured":"Poston, L. et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 4, 1025\u20131036 (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"901_CR9","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1161\/HYPERTENSIONAHA.119.12968","volume":"74","author":"CV Ananth","year":"2019","unstructured":"Ananth, C. V. et al. Changes in the prevalence of chronic hypertension in pregnancy, United States, 1970 to 2010. Hypertension 74, 1089\u20131095 (2019).","journal-title":"Hypertension"},{"key":"901_CR10","doi-asserted-by":"crossref","unstructured":"Care of pregnant women. Boston Med. Surg. J. 166:292\u2013293 (1912).","DOI":"10.1056\/NEJM191202221660805"},{"key":"901_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bpobgyn.2018.12.003","volume":"57","author":"S Jesudason","year":"2019","unstructured":"Jesudason, S. & Tong, A. The patient experience of kidney disease and pregnancy. Best. Pract. Res. Clin. Obstet. Gynaecol. 57, 77\u201388 (2019).","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"901_CR12","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s40620-023-01610-2","volume":"36","author":"ER Ralston","year":"2023","unstructured":"Ralston, E. R. et al. Exploring biopsychosocial correlates of pregnancy risk and pregnancy intention in women with chronic kidney disease. J. Nephrol. 36, 1361\u20131372 (2023).","journal-title":"J. Nephrol."},{"key":"901_CR13","doi-asserted-by":"crossref","unstructured":"Pregnancy and renal disease. Lancet. 2:801\u2013802 (1975).","DOI":"10.1016\/S0140-6736(75)80015-8"},{"key":"901_CR14","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1111\/jan.15659","volume":"79","author":"L Mc Laughlin","year":"2023","unstructured":"Mc Laughlin, L. et al. Feminizing care pathways: mixed-methods study of reproductive options, decision making, pregnancy, post-natal care and parenting amongst women with kidney disease. J. Adv. Nurs. 79, 3127\u20133146 (2023).","journal-title":"J. Adv. Nurs."},{"key":"901_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","volume":"23","author":"C Garlanda","year":"2005","unstructured":"Garlanda, C., Bottazzi, B., Bastone, A. & Mantovani, A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23, 337\u2013366 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"901_CR16","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.3389\/fimmu.2018.02808","volume":"9","author":"A Camaioni","year":"2018","unstructured":"Camaioni A., Klinger F. G., Campagnolo L., Salustri A. The influence of pentraxin 3 on the ovarian function and its impact on fertility. Front. Immunol. 9, 2808 (2018).","journal-title":"Front. Immunol."},{"key":"901_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.semnephrol.2021.03.007","volume":"41","author":"R Rojas","year":"2021","unstructured":"Rojas, R., Clegg, D. J. & Palmer, B. F. Amenorrhea and estrogen disorders in kidney disease. Semin. Nephrol. 41, 126\u2013132 (2021).","journal-title":"Semin. Nephrol."},{"key":"901_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/ckj\/sfz164","volume":"14","author":"K Wiles","year":"2021","unstructured":"Wiles, K. et al. Anti-M\u00fcllerian hormone concentrations in women with chronic kidney disease. Clin. Kidney J. 14, 537\u2013542 (2021).","journal-title":"Clin. Kidney J."},{"key":"901_CR19","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2215\/CJN.03500412","volume":"7","author":"J Gupta","year":"2012","unstructured":"Gupta, J. et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin. J. Am. Soc. Nephrol. 7, 1938\u20131946 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"901_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0272-6386(97)90120-7","volume":"29","author":"JL Holley","year":"1997","unstructured":"Holley, J. L., Schmidt, R. J., Bender, F. H., Dumler, F. & Schiff, M. Gynecologic and reproductive issues in women on dialysis. Am. J. Kidney Dis. 29, 685\u2013690 (1997).","journal-title":"Am. J. Kidney Dis."},{"key":"901_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0272-6386(99)70296-9","volume":"33","author":"S Hou","year":"1999","unstructured":"Hou, S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am. J. Kidney Dis. 33, 235\u2013252 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"901_CR22","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/ndt\/gfab157","volume":"37","author":"E Hewawasam","year":"2022","unstructured":"Hewawasam, E. et al. Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22\u2009years. Nephrol. Dial. Transpl. 37, 1152\u20131161 (2022).","journal-title":"Nephrol. Dial. Transpl."},{"key":"901_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s40620-022-01546-z","volume":"36","author":"WAL Vrijlandt","year":"2023","unstructured":"Vrijlandt, W. A. L. et al. Prevalence of chronic kidney disease in women of reproductive age and observed birth rates. J. Nephrol. 36, 1341\u20131347 (2023).","journal-title":"J. Nephrol."},{"key":"901_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0140-6736(72)90502-8","volume":"1","author":"PR Uldall","year":"1972","unstructured":"Uldall, P. R., Kerr, D. N. & Tacchi, D. Sterility and cyclophosphamide. Lancet. 1, 693\u2013694 (1972).","journal-title":"Lancet."},{"key":"901_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00467-014-2897-1","volume":"30","author":"R Gajjar","year":"2015","unstructured":"Gajjar, R., Miller, S. D., Meyers, K. E. & Ginsberg, J. P. Fertility preservation in patients receiving cyclophosphamide therapy for renal disease. Pediatr. Nephrol. 30, 1099\u20131106 (2015).","journal-title":"Pediatr. Nephrol."},{"key":"901_CR26","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) glomerular diseases work group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 100, S1\u2013S276 (2021)."},{"key":"901_CR27","first-page":"488","volume":"2","author":"VA Dines","year":"2021","unstructured":"Dines, V. A., Garovic, V. D., Parashuram, S., Cosio, F. G. & Kattah, A. G. Pregnancy, contraception, and menopause in advanced chronic kidney disease and kidney transplant. Womens Health Rep. 2, 488\u2013496 (2021).","journal-title":"Womens Health Rep."},{"key":"901_CR28","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.2215\/CJN.07100622","volume":"17","author":"CL Rytz","year":"2022","unstructured":"Rytz, C. L. et al. Menstrual abnormalities and reproductive lifespan in females with CKD: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 17, 1742\u20131753 (2022).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"901_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41581-023-00717-w","volume":"20","author":"VA Dines","year":"2023","unstructured":"Dines, V. A. & Garovic, V. D. Menopause and chronic kidney disease. Nat. Rev. Nephrol. 20, 4\u20135 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"901_CR30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1053\/j.ajkd.2017.12.019","volume":"71","author":"K Vellanki","year":"2018","unstructured":"Vellanki, K. & Hou, S. Menopause in CKD. Am. J. Kidney Dis. 71, 710\u2013719 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"901_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12522-015-0227-3","volume":"15","author":"A Iwase","year":"2015","unstructured":"Iwase, A. et al. Anti\u2010M\u00fcllerian hormone as a marker of ovarian reserve: what have we learned, and what should we know? Reprod. Med. Biol. 15, 127\u2013136 (2015).","journal-title":"Reprod. Med. Biol."},{"key":"901_CR32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.fertnstert.2010.10.011","volume":"95","author":"DB Seifer","year":"2011","unstructured":"Seifer, D. B., Baker, V. L. & Leader, B. Age-specific serum anti-M\u00fcllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil. Steril. 95, 747\u2013750 (2011).","journal-title":"Fertil. Steril."},{"key":"901_CR33","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.crohns.2012.03.003","volume":"7","author":"E \u015eenate\u015f","year":"2013","unstructured":"\u015eenate\u015f, E. et al. Serum anti-M\u00fcllerian hormone levels are lower in reproductive-age women with Crohn\u2019s disease compared to healthy control women. J. Crohns Colitis 7, e29\u2013e34 (2013).","journal-title":"J. Crohns Colitis"},{"key":"901_CR34","first-page":"1152","volume":"24","author":"E Cakmak","year":"2018","unstructured":"Cakmak, E., Karakus, S., Demirpence, O. & Coskun, B. D. Ovarian reserve assessment in celiac patients of reproductive age. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 24, 1152\u20131157 (2018).","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"901_CR35","doi-asserted-by":"publisher","unstructured":"Karampatou, A. et al. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV. J. Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2017.08.019 (2017).","DOI":"10.1016\/j.jhep.2017.08.019"},{"key":"901_CR36","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/09513590.2018.1563884","volume":"35","author":"B Aydogan Mathyk","year":"2019","unstructured":"Aydogan Mathyk, B., Aslan Cetin, B., Bilici, S., Fasse, J. & Avci, P. Evaluation of ovarian reserve in women with psoriasis. Gynecol. Endocrinol. 35, 608\u2013611 (2019).","journal-title":"Gynecol. Endocrinol."},{"key":"901_CR37","doi-asserted-by":"publisher","first-page":"695157","DOI":"10.3389\/fendo.2021.695157","volume":"12","author":"C Lin","year":"2021","unstructured":"Lin, C. et al. The value of anti-M\u00fcllerian hormone in the prediction of spontaneous pregnancy: a systematic review and meta-analysis. Front. Endocrinol. 12, 695157 (2021).","journal-title":"Front. Endocrinol."},{"key":"901_CR38","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jama.2017.14588","volume":"318","author":"AZ Steiner","year":"2017","unstructured":"Steiner, A. Z. et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA 318, 1367\u20131376 (2017).","journal-title":"JAMA"},{"key":"901_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-015-0149-z","volume":"8","author":"R Venturella","year":"2015","unstructured":"Venturella, R. et al. OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters. J. Ovarian Res. 8, 21 (2015).","journal-title":"J. Ovarian Res."},{"key":"901_CR40","doi-asserted-by":"publisher","first-page":"1087429","DOI":"10.3389\/fendo.2023.1087429","volume":"14","author":"T Ding","year":"2023","unstructured":"Ding, T. et al. Assessment and quantification of ovarian reserve on the basis of machine learning models. Front. Endocrinol. 14, 1087429 (2023).","journal-title":"Front. Endocrinol."},{"key":"901_CR41","doi-asserted-by":"publisher","first-page":"648141","DOI":"10.3389\/fendo.2021.648141","volume":"12","author":"W Shah","year":"2021","unstructured":"Shah, W. et al. The molecular mechanism of sex hormones on Sertoli cell development and proliferation. Front. Endocrinol. 12, 648141 (2021).","journal-title":"Front. Endocrinol."},{"key":"901_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mce.2018.12.012","volume":"482","author":"I Bhattacharya","year":"2019","unstructured":"Bhattacharya, I. et al. Testosterone augments FSH signaling by upregulating the expression and activity of FSH-Receptor in Pubertal Primate Sertoli cells. Mol. Cell Endocrinol. 482, 70\u201380 (2019).","journal-title":"Mol. Cell Endocrinol."},{"key":"901_CR43","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/BF03347352","volume":"26","author":"L Scarabelli","year":"2003","unstructured":"Scarabelli, L., Caviglia, D., Bottazzi, C. & Palmero, S. Prolactin effect on pre-pubertal Sertoli cell proliferation and metabolism. J. Endocrinol. Invest. 26, 718\u2013722 (2003).","journal-title":"J. Endocrinol. Invest."},{"key":"901_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0303-7207(96)03891-9","volume":"122","author":"P Guillaumot","year":"1996","unstructured":"Guillaumot, P., Tabone, E. & Benahmed, M. Sertoli cells as potential targets of prolactin action in the testis. Mol. Cell Endocrinol. 122, 199\u2013206 (1996).","journal-title":"Mol. Cell Endocrinol."},{"key":"901_CR45","first-page":"153","volume":"66","author":"C Petersen","year":"2006","unstructured":"Petersen, C. & Soder, O. The Sertoli cell \u2014 a hormonal target and \u2018super\u2019 nurse for germ cells that determines testicular size. Horm. Res. 66, 153\u2013161 (2006).","journal-title":"Horm. Res."},{"key":"901_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/jarr.2003.50003","volume":"10","author":"BF Palmer","year":"2003","unstructured":"Palmer, B. F. Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. Adv. Ren. Replace. Ther. 10, 48\u201360 (2003).","journal-title":"Adv. Ren. Replace. Ther."},{"key":"901_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/1008-682X.135124","volume":"17","author":"D Eckersten","year":"2015","unstructured":"Eckersten, D., Giwercman, A. & Christensson, A. Male patients with terminal renal failure exhibit low serum levels of antim\u00fcllerian hormone. Asian J. Androl. 17, 149\u2013153 (2015).","journal-title":"Asian J. Androl."},{"key":"901_CR48","doi-asserted-by":"publisher","first-page":"687259","DOI":"10.1155\/2009\/687259","volume":"2009","author":"MK Gill-Sharma","year":"2009","unstructured":"Gill-Sharma, M. K. Prolactin and male fertility: the long and short feedback regulation. Int. J. Endocrinol. 2009, 687259 (2009).","journal-title":"Int. J. Endocrinol."},{"key":"901_CR49","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.3390\/nu14163438","volume":"14","author":"K Romejko","year":"2022","unstructured":"Romejko, K., Rymarz, A., Sadownik, H. & Niemczyk, S. Testosterone deficiency as one of the major endocrine disorders in chronic kidney disease. Nutrients 14, 3438 (2022).","journal-title":"Nutrients"},{"key":"901_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.ajkd.2014.03.010","volume":"64","author":"KK Khurana","year":"2014","unstructured":"Khurana, K. K. et al. Serum testosterone levels and mortality in men with CKD stages 3\u20134. Am. J. Kidney Dis. 64, 367\u2013374 (2014).","journal-title":"Am. J. Kidney Dis."},{"key":"901_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.euros.2021.05.008","volume":"29","author":"RJ Fantus","year":"2021","unstructured":"Fantus, R. J. et al. Serum total testosterone and premature mortality among men in the USA. Eur. Urol. Open. Sci. 29, 89\u201392 (2021).","journal-title":"Eur. Urol. Open. Sci."},{"key":"901_CR52","first-page":"181","volume":"33","author":"S Ros","year":"2013","unstructured":"Ros, S. & Carrero, J. J. Endocrine alterations and cardiovascular risk in CKD: is there a link? Nefrol. Engl. Ed. 33, 181\u2013187 (2013).","journal-title":"Nefrol. Engl. Ed."},{"key":"901_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/ijir.2009.46","volume":"22","author":"A Guay","year":"2010","unstructured":"Guay, A., Seftel, A. D. & Traish, A. Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses. Int. J. Impot. Res. 22, 9\u201319 (2010).","journal-title":"Int. J. Impot. Res."},{"key":"901_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2369-13-67","volume":"13","author":"A Bass","year":"2012","unstructured":"Bass, A. et al. The impact of nocturnal hemodialysis on sexual function. BMC Nephrol. 13, 67 (2012).","journal-title":"BMC Nephrol."},{"key":"901_CR55","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1440-1797.2011.01520.x","volume":"17","author":"C Van Eps","year":"2012","unstructured":"Van Eps, C. et al. Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis. Nephrology 17, 42\u201347 (2012).","journal-title":"Nephrology"},{"key":"901_CR56","doi-asserted-by":"publisher","first-page":"187","DOI":"10.17219\/acem\/141188","volume":"31","author":"P Kuczera","year":"2022","unstructured":"Kuczera, P., Wi\u0119cek, A. & Adamczak, M. Impaired fertility in women and men with chronic kidney disease. Adv. Clin. Exp. Med. 31, 187\u2013195 (2022).","journal-title":"Adv. Clin. Exp. Med."},{"key":"901_CR57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000484992","volume":"138","author":"D Eckersten","year":"2017","unstructured":"Eckersten, D., Giwercman, A., Pihlsg\u00e5rd, M., Bruun, L. & Christensson, A. Impact of kidney transplantation on reproductive hormone levels in males: a longitudinal study. Nephron 138, 192\u2013201 (2017).","journal-title":"Nephron"},{"key":"901_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/and.14158","volume":"53","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Kidney transplantation improve semen quality in patients with dialysis: a systematic review and meta-analysis. Andrologia 53, e14158 (2021).","journal-title":"Andrologia"},{"key":"901_CR59","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/and.12388","volume":"47","author":"M Lehtihet","year":"2015","unstructured":"Lehtihet, M. & Hylander, B. Semen quality in men with chronic kidney disease and its correlation with chronic kidney disease stages. Andrologia 47, 1103\u20131108 (2015).","journal-title":"Andrologia"},{"key":"901_CR60","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3390\/life11121368","volume":"11","author":"F Boitrelle","year":"2021","unstructured":"Boitrelle, F. et al. The sixth edition of the WHO manual for human semen analysis: a critical review and SWOT analysis. Life 11, 1368 (2021).","journal-title":"Life"},{"key":"901_CR61","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/S0140-6736(97)10514-1","volume":"352","author":"JP Bonde","year":"1998","unstructured":"Bonde, J. P. et al. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet Lond. Engl. 352, 1172\u20131177 (1998).","journal-title":"Lancet Lond. Engl."},{"key":"901_CR62","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/humrep\/17.2.503","volume":"17","author":"R Slama","year":"2002","unstructured":"Slama, R. et al. Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum. Reprod. Oxf. Engl. 17, 503\u2013515 (2002).","journal-title":"Hum. Reprod. Oxf. Engl."},{"key":"901_CR63","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.rbmo.2022.03.011","volume":"45","author":"L Bj\u00f6rndahl","year":"2022","unstructured":"Bj\u00f6rndahl, L. A paradigmatic shift in the care of male factor infertility: how can the recommendations for basic semen examination in the sixth edition of the WHO manual and the ISO 23162:2021 standard help? Reprod. Biomed. Online 45, 731\u2013736 (2022).","journal-title":"Reprod. Biomed. Online"},{"key":"901_CR64","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41585-022-00593-2","volume":"19","author":"SC Esteves","year":"2022","unstructured":"Esteves, S. C. Evolution of the World Health Organization semen analysis manual: where are we? Nat. Rev. Urol. 19, 439\u2013446 (2022).","journal-title":"Nat. Rev. Urol."},{"key":"901_CR65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.rbmo.2020.09.016","volume":"42","author":"L Haddock","year":"2021","unstructured":"Haddock, L. et al. Sperm DNA fragmentation is a novel biomarker for early pregnancy loss. Reprod. Biomed. Online 42, 175\u2013184 (2021).","journal-title":"Reprod. Biomed. Online"},{"key":"901_CR66","doi-asserted-by":"publisher","first-page":"802632","DOI":"10.3389\/fendo.2021.802632","volume":"12","author":"Y Dai","year":"2021","unstructured":"Dai, Y. Relationship among traditional semen parameters, sperm DNA fragmentation, and unexplained recurrent miscarriage: a systematic review and meta-analysis. Front. Endocrinol. 12, 802632 (2021).","journal-title":"Front. Endocrinol."},{"key":"901_CR67","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.fertnstert.2019.04.029","volume":"112","author":"E Borges","year":"2019","unstructured":"Borges, E. et al. Sperm DNA fragmentation is correlated with poor embryo development, lower implantation rate, and higher miscarriage rate in reproductive cycles of non-male factor infertility. Fertil. Steril. 112, 483\u2013490 (2019).","journal-title":"Fertil. Steril."},{"key":"901_CR68","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/genes10030236","volume":"10","author":"ST Homa","year":"2019","unstructured":"Homa, S. T. et al. A comparison between two assays for measuring seminal oxidative stress and their relationship with sperm DNA fragmentation and semen parameters. Genes 10, 236 (2019).","journal-title":"Genes"},{"key":"901_CR69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/molehr\/gap059","volume":"16","author":"RJ Aitken","year":"2010","unstructured":"Aitken, R. J. & De Iuliis, G. N. On the possible origins of DNA damage in human spermatozoa. Mol. Hum. Reprod. 16, 3\u201313 (2010).","journal-title":"Mol. Hum. Reprod."},{"key":"901_CR70","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.3390\/ijms20153711","volume":"20","author":"A Duni","year":"2019","unstructured":"Duni, A., Liakopoulos, V., Roumeliotis, S., Peschos, D. & Dounousi, E. Oxidative stress in the pathogenesis and evolution of chronic kidney disease: untangling Ariadne\u2019s thread. Int. J. Mol. Sci. 20, 3711 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"901_CR71","volume":"11","author":"A Javadneia","year":"2019","unstructured":"Javadneia, A. et al. Sperm DNA damage before and after kidney transplantation. Nephro-Urol. Mon. 11, e86990 (2019).","journal-title":"Nephro-Urol. Mon."},{"key":"901_CR72","first-page":"CD008176","volume":"11","author":"JM Colombijn","year":"2023","unstructured":"Colombijn, J. M. et al. Antioxidants for adults with chronic kidney disease. Cochrane Database Syst. Rev. 11, CD008176 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"key":"901_CR73","first-page":"CD007411","volume":"5","author":"W de Ligny","year":"2022","unstructured":"de Ligny, W. et al. Antioxidants for male subfertility. Cochrane Database Syst. Rev. 5, CD007411 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"901_CR74","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jsxm.2020.10.012","volume":"18","author":"N Pyrgidis","year":"2021","unstructured":"Pyrgidis, N. et al. Prevalence of erectile dysfunction in patients with end-stage renal disease: a systematic review and meta-analysis. J. Sex. Med. 18, 113\u2013120 (2021).","journal-title":"J. Sex. Med."},{"key":"901_CR75","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fmed.2017.00032","volume":"4","author":"MM Edey","year":"2017","unstructured":"Edey, M. M. Male sexual dysfunction and chronic kidney disease. Front. Med. 4, 32 (2017).","journal-title":"Front. Med."},{"key":"901_CR76","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrurol.2018.20","volume":"15","author":"F Lotti","year":"2018","unstructured":"Lotti, F. & Maggi, M. Sexual dysfunction and male infertility. Nat. Rev. Urol. 15, 287\u2013307 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"901_CR77","doi-asserted-by":"crossref","unstructured":"Vecchio, M. et al. Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst. Rev. 8, CD007747 (2010).","DOI":"10.1002\/14651858.CD007747.pub2"},{"key":"901_CR78","doi-asserted-by":"publisher","first-page":"173","DOI":"10.21037\/tau.2018.07.16","volume":"8","author":"SD Lundy","year":"2019","unstructured":"Lundy, S. D. & Vij, S. C. Male infertility in renal failure and transplantation. Transl. Androl. Urol. 8, 173\u2013181 (2019).","journal-title":"Transl. Androl. Urol."},{"key":"901_CR79","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/03915603221114612","volume":"89","author":"S Mondal","year":"2022","unstructured":"Mondal, S., Sinha Roy, P. P. & Pal, D. K. Sexual well-being and fertility in male renal transplant recipients: a study in a tertiary care centre. Urol. J. 89, 636\u2013640 (2022).","journal-title":"Urol. J."},{"key":"901_CR80","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/TP.0000000000000173","volume":"98","author":"J Tainio","year":"2014","unstructured":"Tainio, J. et al. Testicular function, semen quality, and fertility in young men after renal transplantation during childhood or adolescence. Transplantation 98, 987\u2013993 (2014).","journal-title":"Transplantation"},{"key":"901_CR81","doi-asserted-by":"publisher","first-page":"e1152","DOI":"10.1016\/S2214-109X(20)30315-6","volume":"8","author":"J Bearak","year":"2020","unstructured":"Bearak, J. et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990\u20132019. Lancet Glob. Health 8, e1152\u2013e1161 (2020).","journal-title":"Lancet Glob. Health"},{"key":"901_CR82","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1016\/j.transproceed.2005.07.060","volume":"37","author":"S Ghazizadeh","year":"2005","unstructured":"Ghazizadeh, S. et al. Unwanted pregnancy among kidney transplant recipients in Iran. Transpl. Proc. 37, 3085\u20133086 (2005).","journal-title":"Transpl. Proc."},{"key":"901_CR83","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.transproceed.2004.04.090","volume":"36","author":"M Lessan-Pezeshki","year":"2004","unstructured":"Lessan-Pezeshki, M. et al. Fertility and contraceptive issues after kidney transplantation in women. Transpl. Proc. 36, 1405\u20131406 (2004).","journal-title":"Transpl. Proc."},{"key":"901_CR84","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40620-021-01181-0","volume":"35","author":"S Shah","year":"2022","unstructured":"Shah, S., Christianson, A. L., Bumb, S. & Verma, P. Contraceptive use among women with kidney transplants in the United States. J. Nephrol. 35, 629\u2013638 (2022).","journal-title":"J. Nephrol."},{"key":"901_CR85","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1188\/17.CJON.189-196","volume":"21","author":"L Britton","year":"2017","unstructured":"Britton, L. Unintended pregnancy: a systematic review of contraception use and counseling in women with cancer. Clin. J. Oncol. Nurs. 21, 189\u2013196 (2017).","journal-title":"Clin. J. Oncol. Nurs."},{"key":"901_CR86","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1089\/jwh.2015.5576","volume":"25","author":"GS Phillips-Bell","year":"2016","unstructured":"Phillips-Bell, G. S., Sappenfield, W., Robbins, C. L. & Hernandez, L. Chronic diseases and use of contraception among women at risk of unintended pregnancy. J. Womens Health 25, 1262\u20131269 (2016).","journal-title":"J. Womens Health"},{"key":"901_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-022-01413-x","volume":"19","author":"ML Harris","year":"2022","unstructured":"Harris, M. L. et al. Patterns of contraceptive use among young Australian women with chronic disease: findings from a prospective cohort study. Reprod. Health 19, 111 (2022).","journal-title":"Reprod. Health"},{"key":"901_CR88","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12882-017-0553-2","volume":"18","author":"RJ Baker","year":"2017","unstructured":"Baker, R. J., Mark, P. B., Patel, R. K., Stevens, K. K. & Palmer, N. Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol. 18, 174 (2017).","journal-title":"BMC Nephrol."},{"key":"901_CR89","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12882-019-1560-2","volume":"20","author":"K Wiles","year":"2019","unstructured":"Wiles, K. et al. Clinical practice guideline on pregnancy and renal disease. BMC Nephrol. 20, 401 (2019).","journal-title":"BMC Nephrol."},{"key":"901_CR90","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/2042098614548857","volume":"5","author":"J Brynhildsen","year":"2014","unstructured":"Brynhildsen, J. Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks. Ther. Adv. Drug. Saf. 5, 201\u2013213 (2014).","journal-title":"Ther. Adv. Drug. Saf."},{"key":"901_CR91","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s40620-020-00717-0","volume":"33","author":"R Attini","year":"2020","unstructured":"Attini, R. et al. Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology. J. Nephrol. 33, 1343\u20131359 (2020).","journal-title":"J. Nephrol."},{"key":"901_CR92","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/AOG.0b013e318183464e","volume":"112","author":"H Browne","year":"2008","unstructured":"Browne, H., Manipalviratn, S. & Armstrong, A. Using an intrauterine device in immunocompromised women. Obstet. Gynecol. 112, 667\u2013669 (2008).","journal-title":"Obstet. Gynecol."},{"key":"901_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36119-6","volume":"14","author":"M Balbach","year":"2023","unstructured":"Balbach, M. et al. On-demand male contraception via acute inhibition of soluble adenylyl cyclase. Nat. Commun. 14, 637 (2023).","journal-title":"Nat. Commun."},{"key":"901_CR94","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/biology13050291","volume":"13","author":"JN Koilpillai","year":"2024","unstructured":"Koilpillai, J. N., Nunan, E., Butler, L., Pinaffi, F. & Butcher, J. T. Reversible contraception in males: an obtainable target? Biology 13, 291 (2024).","journal-title":"Biology"},{"key":"901_CR95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40265-018-1038-8","volume":"79","author":"A Thirumalai","year":"2019","unstructured":"Thirumalai, A. & Page, S. T. Recent developments in male contraception. Drugs 79, 11\u201320 (2019).","journal-title":"Drugs"},{"key":"901_CR96","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","volume":"83","author":"J Trussell","year":"2011","unstructured":"Trussell, J. Contraceptive failure in the United States. Contraception 83, 397\u2013404 (2011).","journal-title":"Contraception"},{"key":"901_CR97","first-page":"603","volume":"93","author":"CR Abbe","year":"2020","unstructured":"Abbe, C. R., Page, S. T. & Thirumalai, A. Male contraception. Yale J. Biol. Med. 93, 603\u2013613 (2020).","journal-title":"Yale J. Biol. Med."},{"key":"901_CR98","first-page":"13","volume":"19","author":"M Berer","year":"2017","unstructured":"Berer, M. Abortion law and policy around the world. Health Hum. Rights 19, 13\u201327 (2017).","journal-title":"Health Hum. Rights"},{"key":"901_CR99","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41581-022-00634-4","volume":"18","author":"A Qi","year":"2022","unstructured":"Qi, A. & Hladunewich, M. A. Nephrology and women\u2019s health post-Roe v. Wade: we must do better. Nat. Rev. Nephrol. 18, 741\u2013742 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"901_CR100","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2215\/CJN.0000000000000027","volume":"18","author":"K Rizzolo","year":"2023","unstructured":"Rizzolo, K., Faucett, A. & Kendrick, J. Implications of antiabortion laws on patients with kidney disease in pregnancy. Clin. J. Am. Soc. Nephrol. 18, 276\u2013278 (2023).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"901_CR101","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/NMD.0000000000001596","volume":"210","author":"GE Robinson","year":"2022","unstructured":"Robinson, G. E. et al. The mental and physical health impacts of overturning Roe v Wade. J. Nerv. Ment. Dis. 210, 891\u2013893 (2022).","journal-title":"J. Nerv. Ment. Dis."},{"key":"901_CR102","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/ndt\/gfu092","volume":"29","author":"GB Piccoli","year":"2014","unstructured":"Piccoli, G. B. et al. The children of dialysis: live-born babies from on-dialysis mothers in Italy \u2014 an epidemiological perspective comparing dialysis, kidney transplantation and the overall population. Nephrol. Dial. Transpl. 29, 1578\u20131586 (2014).","journal-title":"Nephrol. Dial. Transpl."},{"key":"901_CR103","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.semnephrol.2017.05.004","volume":"37","author":"SB Ahmed","year":"2017","unstructured":"Ahmed, S. B., Vitek, W. S. & Holley, J. L. Fertility, contraception, and novel reproductive technologies in chronic kidney disease. Semin. Nephrol. 37, 327\u2013336 (2017).","journal-title":"Semin. Nephrol."},{"key":"901_CR104","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000485157","volume":"45","author":"J Tangren","year":"2018","unstructured":"Tangren, J., Nadel, M. & Hladunewich, M. A. Pregnancy and end-stage renal disease. Blood Purif. 45, 194\u2013200 (2018).","journal-title":"Blood Purif."},{"key":"901_CR105","doi-asserted-by":"crossref","unstructured":"Horsey K. The future of surrogacy: a review of current global trends and national landscapes. Reprod Biomed Online. 48, 103764.","DOI":"10.1016\/j.rbmo.2023.103764"},{"key":"901_CR106","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000508600","volume":"51","author":"A Madej","year":"2020","unstructured":"Madej, A., Mazanowska, N., Cyganek, A., Pazik, J. & Pietrzak, B. Neonatal and maternal outcomes among women with glomerulonephritis. Am. J. Nephrol. 51, 534\u2013541 (2020).","journal-title":"Am. J. Nephrol."},{"key":"901_CR107","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","volume":"82","author":"NM Sifontis","year":"2006","unstructured":"Sifontis, N. M. et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82, 1698\u20131702 (2006).","journal-title":"Transplantation"},{"key":"901_CR108","unstructured":"Drugs and Lactation Database (LactMed). National Center for Biotechnology Information https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501922\/ (2006)."},{"key":"901_CR109","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/rheumatology\/kev404","volume":"55","author":"J Flint","year":"2016","unstructured":"Flint, J. et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatol. Oxf. Engl. 55, 1693\u20131697 (2016).","journal-title":"Rheumatol. Oxf. Engl."},{"key":"901_CR110","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrrheum.2012.106","volume":"8","author":"DJ Wallace","year":"2012","unstructured":"Wallace, D. J., Gudsoorkar, V. S., Weisman, M. H. & Venuturupalli, S. R. New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. Nat. Rev. Rheumatol. 8, 522\u2013533 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"901_CR111","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/archinte.1992.00400150093017","volume":"152","author":"D Zemlickis","year":"1992","unstructured":"Zemlickis, D. et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch. Intern. Med. 152, 573\u2013576 (1992).","journal-title":"Arch. Intern. Med."},{"key":"901_CR112","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/ckj\/sfab049","volume":"14","author":"H Boulay","year":"2021","unstructured":"Boulay, H. et al. Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review. Clin. Kidney J. 14, 1871\u20131878 (2021).","journal-title":"Clin. Kidney J."},{"key":"901_CR113","doi-asserted-by":"publisher","first-page":"rkaa074","DOI":"10.1093\/rap\/rkaa074","volume":"5","author":"K Perrotta","year":"2021","unstructured":"Perrotta, K., Kiernan, E., Bandoli, G., Manaster, R. & Chambers, C. Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series. Rheumatol. Adv. Pract. 5, rkaa074 (2021).","journal-title":"Rheumatol. Adv. Pract."},{"key":"901_CR114","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.semarthrit.2021.06.005","volume":"51","author":"JH Kao","year":"2021","unstructured":"Kao, J. H. et al. Pregnancy outcomes in patients treated with belimumab: report from real-world experience. Semin. Arthritis Rheum. 51, 963\u2013968 (2021).","journal-title":"Semin. Arthritis Rheum."},{"key":"901_CR115","unstructured":"FDA. Rapamune. (sirolimus) drug information sheet. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2003\/021083s006lbl.pdf."},{"key":"901_CR116","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/jcm7120552","volume":"7","author":"C Ponticelli","year":"2018","unstructured":"Ponticelli, C. & Moroni, G. Fetal toxicity of immunosuppressive drugs in pregnancy. J. Clin. Med. 7, 552 (2018).","journal-title":"J. Clin. Med."},{"key":"901_CR117","doi-asserted-by":"publisher","first-page":"19","DOI":"10.22551\/2021.31.0802.10180","volume":"8","author":"S Tshering","year":"2021","unstructured":"Tshering, S., Dorji, N., Youden, S. & Wangchuk, D. Maternal sirolimus therapy and fetal growth restriction. Arch. Clin. Cases 8, 19\u201324 (2021).","journal-title":"Arch. Clin. Cases"},{"key":"901_CR118","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/S0140-6736(05)64207-9","volume":"350","author":"GY Lip","year":"1997","unstructured":"Lip, G. Y., Churchill, D., Beevers, M., Auckett, A. & Beevers, D. G. Angiotensin-converting-enzyme inhibitors in early pregnancy. Lancet. 350, 1446\u20131447 (1997).","journal-title":"Lancet."},{"key":"901_CR119","first-page":"240","volume":"46","author":"Centers for Disease Control and Prevention (CDC","year":"1997","unstructured":"Centers for Disease Control and Prevention (CDC). Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy \u2014 United States, Canada, and Israel, 1987\u20131995. MMWR Morb. Mortal. Wkly. Rep. 46, 240\u2013242 (1997).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"901_CR120","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3233\/JRS-1997-10102","volume":"10","author":"J Bar","year":"1997","unstructured":"Bar, J., Hod, M. & Merlob, P. Angiotensin converting enzyme inhibitors use in the first trimester of pregnancy. Int. J. Risk Saf. Med. 10, 23\u201326 (1997).","journal-title":"Int. J. Risk Saf. Med."},{"key":"901_CR121","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0140-6736(05)78584-6","volume":"351","author":"FH Steffensen","year":"1998","unstructured":"Steffensen, F. H., Nielsen, G. L., S\u00f8rensen, H. T., Olesen, C. & Olsen, J. Pregnancy outcome with ACE-inhibitor use in early pregnancy. Lancet Lond. Engl. 351, 596 (1998).","journal-title":"Lancet Lond. Engl."},{"key":"901_CR122","doi-asserted-by":"publisher","first-page":"d5931","DOI":"10.1136\/bmj.d5931","volume":"343","author":"DK Li","year":"2011","unstructured":"Li, D. K., Yang, C., Andrade, S., Tavares, V. & Ferber, J. R. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 343, d5931 (2011).","journal-title":"BMJ"},{"key":"901_CR123","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1055\/s-0030-1269895","volume":"223","author":"C H\u00fcnseler","year":"2011","unstructured":"H\u00fcnseler, C. et al. Angiotensin II receptor blocker induced fetopathy: 7 cases. Klin. P\u00e4diatr. 223, 10\u201314 (2011).","journal-title":"Klin. P\u00e4diatr."},{"key":"901_CR124","first-page":"451","volume":"40","author":"JF Mosley","year":"2015","unstructured":"Mosley, J. F., Smith, L., Everton, E. & Fellner, C. Sodium-glucose linked transporter 2 (SGLT2) inhibitors in the management of type-2 diabetes: a drug class overview. Pharm. Ther. 40, 451\u2013462 (2015).","journal-title":"Pharm. Ther."},{"key":"901_CR125","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1681\/ASN.0000000000000053","volume":"34","author":"J Tangren","year":"2023","unstructured":"Tangren, J. et al. Pre-Pregnancy eGFR and the risk of adverse maternal and fetal outcomes: a population-based study. J. Am. Soc. Nephrol. 34, 656\u2013667 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"901_CR126","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.semnephrol.2017.05.008","volume":"37","author":"K Bramham","year":"2017","unstructured":"Bramham, K. Diabetic nephropathy and pregnancy. Semin. Nephrol. 37, 362\u2013369 (2017).","journal-title":"Semin. Nephrol."},{"key":"901_CR127","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018494","volume":"10","author":"S Al Khalaf","year":"2021","unstructured":"Al Khalaf, S. et al. Impact of chronic hypertension and antihypertensive treatment on adverse perinatal outcomes: systematic review and meta-analysis. J. Am. Heart Assoc. 10, e018494 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"901_CR128","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1093\/ndt\/gfaa247","volume":"36","author":"K Wiles","year":"2021","unstructured":"Wiles, K. et al. The impact of chronic kidney disease stages 3\u20135 on pregnancy outcomes. Nephrol. Dial. Transpl. 36, 2008\u20132017 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"901_CR129","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1681\/ASN.2014050459","volume":"26","author":"GB Piccoli","year":"2015","unstructured":"Piccoli, G. B. et al. Risk of adverse pregnancy outcomes in women with CKD. J. Am. Soc. Nephrol. 26, 2011\u20132022 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"901_CR130","unstructured":"EMA recommends additional measures to prevent use of mycophenolate in pregnancy. 2015. Available: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/ (2015)."},{"key":"901_CR131","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/bdra.23556","volume":"106","author":"P Damkier","year":"2016","unstructured":"Damkier, P., Passier, A., Bo Petersen, L., Havnen, G. & Thestrup Pedersen, A. J. Changing of the guards: EMA warning on paternal use of mycophenolate mofetil: an unnecessary and insufficiently substantiated precaution. Birth Defects Res. A Clin. Mol. Teratol. 106, 860\u2013861 (2016).","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"901_CR132","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1097\/TP.0000000000001747","volume":"101","author":"K Midtvedt","year":"2017","unstructured":"Midtvedt, K., Bergan, S., Reis\u00e6ter, A. V., Vikse, B. E. & \u00c5sberg, A. Exposure to mycophenolate and fatherhood. Transplantation 101, e214\u2013e217 (2017).","journal-title":"Transplantation"},{"key":"901_CR133","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/FTD.0000000000000769","volume":"42","author":"HL Le","year":"2020","unstructured":"Le, H. L. et al. Usage of tacrolimus and mycophenolic acid during conception, pregnancy, and lactation, and its implications for therapeutic drug monitoring: a systematic critical review. Ther. Drug. Monit. 42, 518\u2013531 (2020).","journal-title":"Ther. Drug. Monit."},{"key":"901_CR134","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12882-020-02115-x","volume":"21","author":"A Boyer","year":"2020","unstructured":"Boyer, A. et al. Paternity in male kidney transplant recipients: a French national survey, the PATeRNAL study. BMC Nephrol. 21, 483 (2020).","journal-title":"BMC Nephrol."},{"key":"901_CR135","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1053\/j.ajkd.2020.03.020","volume":"76","author":"S Jesudason","year":"2020","unstructured":"Jesudason, S. et al. Fatherhood and kidney replacement therapy: analysis of the Australian and New Zealand dialysis and transplant (ANZDATA) registry. Am. J. Kidney Dis. 76, 444\u2013446 (2020).","journal-title":"Am. J. Kidney Dis."},{"key":"901_CR136","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJM199607253350402","volume":"335","author":"DC Jones","year":"1996","unstructured":"Jones, D. C. & Hayslett, J. P. Outcome of pregnancy in women with moderate or severe renal insufficiency. N. Engl. J. Med. 335, 226\u2013232 (1996).","journal-title":"N. Engl. J. Med."},{"key":"901_CR137","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/1933719110395403","volume":"18","author":"K Bramham","year":"2011","unstructured":"Bramham, K. et al. Pregnancy outcome in women with chronic kidney disease: a prospective cohort study. Reprod. Sci. 18, 623\u2013630 (2011).","journal-title":"Reprod. Sci."},{"key":"901_CR138","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.kint.2015.10.012","volume":"89","author":"K Bramham","year":"2016","unstructured":"Bramham, K. et al. Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int. 89, 874\u2013885 (2016).","journal-title":"Kidney Int."},{"key":"901_CR139","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s40620-018-0509-z","volume":"31","author":"Y He","year":"2018","unstructured":"He, Y. et al. The pregnancy outcomes in patients with stage 3\u20134 chronic kidney disease and the effects of pregnancy in the long-term kidney function. J. Nephrol. 31, 953\u2013960 (2018).","journal-title":"J. Nephrol."},{"key":"901_CR140","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ekir.2023.01.036","volume":"8","author":"ML Reynolds","year":"2023","unstructured":"Reynolds, M. L. et al. Pregnancy history and kidney disease progression among women enrolled in cure glomerulonephropathy. Kidney Int. Rep. 8, 805\u2013817 (2023).","journal-title":"Kidney Int. Rep."},{"key":"901_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002955","volume":"16","author":"RW Major","year":"2019","unstructured":"Major, R. W. et al. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study. PLoS Med. 16, e1002955 (2019).","journal-title":"PLoS Med."},{"key":"901_CR142","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.ekir.2021.03.248","volume":"6","author":"E Ralston","year":"2021","unstructured":"Ralston, E. et al. POS-234 pregnancy-associated progression of chronic kidney disease: development of a clinical predictive tool. Kidney Int. Rep. 6, S99 (2021).","journal-title":"Kidney Int. Rep."},{"key":"901_CR143","doi-asserted-by":"crossref","unstructured":"Ralston, E. et al. Pregnancy-associated progression of chronic kidney disease: a study protocol for the development and validation of a clinical predictive tool (PREDICT). J. Nephrol. 3, 773\u2013776 https:\/\/clinicaltrials.gov\/study\/NCT05793346 (2024).","DOI":"10.1007\/s40620-023-01788-5"},{"key":"901_CR144","doi-asserted-by":"crossref","unstructured":"Smith, P. et al. ORCHARD: a model for conducting pragmatic randomised trials in pregnancy. J. Nephrol. 37, 1411\u20141413 (2024).","DOI":"10.1007\/s40620-024-01952-5"},{"key":"901_CR145","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/HYPERTENSIONAHA.107.103523","volume":"51","author":"AJ Webb","year":"2008","unstructured":"Webb, A. J. et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51, 784\u2013790 (2008).","journal-title":"Hypertension"},{"key":"901_CR146","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.niox.2017.01.011","volume":"64","author":"S Kemmner","year":"2017","unstructured":"Kemmner, S. et al. Dietary nitrate load lowers blood pressure and renal resistive index in patients with chronic kidney disease: a pilot study. Nitric Oxide Biol. Chem. 64, 7\u201315 (2017).","journal-title":"Nitric Oxide Biol. Chem."},{"key":"901_CR147","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.niox.2018.08.004","volume":"80","author":"L Ormesher","year":"2018","unstructured":"Ormesher, L. et al. Effects of dietary nitrate supplementation, from beetroot juice, on blood pressure in hypertensive pregnant women: a randomised, double-blind, placebo-controlled feasibility trial. Nitric Oxide 80, 37\u201344 (2018).","journal-title":"Nitric Oxide"},{"key":"901_CR148","unstructured":"ORCHARD: Study to prevent progression of kidney disease in pregnancy. https:\/\/www.isrctn.com\/ISRCTN91211980."},{"key":"901_CR149","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40620-016-0285-6","volume":"29","author":"G Cabiddu","year":"2016","unstructured":"Cabiddu, G. et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J. Nephrol. 29, 277\u2013303 (2016).","journal-title":"J. Nephrol."},{"key":"901_CR150","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.ekir.2022.09.029","volume":"7","author":"MFC Jong","year":"2022","unstructured":"Jong, M. F. C., de, Hamersvelt, H. W., van, Empel, I. W. H., van, Nijkamp, E. J. W. & Lely, A. T. Summary of the Dutch practice guideline on pregnancy wish and pregnancy in CKD. Kidney Int. Rep. 7, 2575\u20132588 (2022).","journal-title":"Kidney Int. Rep."},{"key":"901_CR151","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7326\/M13-2844","volume":"160","author":"JT Henderson","year":"2014","unstructured":"Henderson, J. T. et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 160, 695\u2013703 (2014).","journal-title":"Ann. Intern. Med."},{"key":"901_CR152","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik, D. L. et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377, 613\u2013622 (2017).","journal-title":"N. Engl. J. Med."},{"key":"901_CR153","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","volume":"57","author":"C Gordon","year":"2018","unstructured":"Gordon, C. et al. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatol. Oxf. Engl. 57, e1\u2013e45 (2018).","journal-title":"Rheumatol. Oxf. Engl."},{"key":"901_CR154","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2009.119263","volume":"69","author":"PM Izmirly","year":"2010","unstructured":"Izmirly, P. M. et al. Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann. Rheum. Dis. 69, 1827\u20131830 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"901_CR155","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/rheumatology\/kex191","volume":"56","author":"J Barsalou","year":"2017","unstructured":"Barsalou, J. et al. Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study. Rheumatol. Oxf. Engl. 56, 1552\u20131559 (2017).","journal-title":"Rheumatol. Oxf. Engl."},{"key":"901_CR156","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1515\/jpm-2020-0543","volume":"49","author":"JM Derdulska","year":"2021","unstructured":"Derdulska, J. M. et al. Neonatal lupus erythematosus \u2014 practical guidelines. J. Perinat. Med. 49, 529\u2013538 (2021).","journal-title":"J. Perinat. Med."},{"key":"901_CR157","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/10641950701204554","volume":"26","author":"HK Ahn","year":"2007","unstructured":"Ahn, H. K. et al. Exposure to amlodipine in the first trimester of pregnancy and during breastfeeding. Hypertens. Pregnancy 26, 179\u2013187 (2007).","journal-title":"Hypertens. Pregnancy"},{"key":"901_CR158","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012093","volume":"8","author":"A Mito","year":"2019","unstructured":"Mito, A. et al. Safety of amlodipine in early pregnancy. J. Am. Heart Assoc. 8, e012093 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"901_CR159","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.preghy.2023.01.001","volume":"31","author":"T Ishikawa","year":"2023","unstructured":"Ishikawa, T. et al. Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: a large claims database study 2010\u20132019. Pregnancy Hypertens. 31, 73\u201383 (2023).","journal-title":"Pregnancy Hypertens."},{"key":"901_CR160","doi-asserted-by":"publisher","first-page":"60.e1","DOI":"10.1016\/j.ajog.2010.01.080","volume":"203","author":"A Benachi","year":"2010","unstructured":"Benachi, A. et al. Down syndrome maternal serum screening in patients with renal disease. Am. J. Obstet. Gynecol. 203, 60.e1\u2013e4 (2010).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"901_CR161","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/pd.4528","volume":"35","author":"M Valentin","year":"2015","unstructured":"Valentin, M. et al. First-trimester combined screening for trisomy 21 in women with renal disease. Prenat. Diagn. 35, 244\u2013248 (2015).","journal-title":"Prenat. Diagn."},{"key":"901_CR162","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/tme.12091","volume":"24","author":"H Qureshi","year":"2014","unstructured":"Qureshi, H. et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus. Med. Oxf. Engl. 24, 8\u201320 (2014).","journal-title":"Transfus. Med. Oxf. Engl."},{"key":"901_CR163","unstructured":"National Institute for Health and Care Excellence. Antenatal Care [NICE Guideline No. 201] https:\/\/www.nice.org.uk\/guidance\/ng201\/chapter\/Recommendations#routine-antenatal-clinical-care (2021)."},{"key":"901_CR164","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.2215\/CJN.10841210","volume":"6","author":"IF Nevis","year":"2011","unstructured":"Nevis, I. F. et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin. J. Am. Soc. Nephrol. 6, 2587\u20132598 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"901_CR165","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2215\/CJN.09250914","volume":"10","author":"JJ Zhang","year":"2015","unstructured":"Zhang, J. J. et al. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin. J. Am. Soc. Nephrol. 10, 1964\u20131978 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"901_CR166","first-page":"S1","volume":"77","author":"NICE guideline.","year":"2019","unstructured":"NICE guideline. Hypertension in pregnancy: diagnosis and management. Am. J. Obstet. Gynecol. 77, S1\u2013S22 (2019).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"901_CR167","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.ackd.2020.06.001","volume":"27","author":"AL Oliverio","year":"2020","unstructured":"Oliverio, A. L. & Hladunewich, M. A. End stage kidney disease and dialysis in pregnancy. Adv. Chronic Kidney Dis. 27, 477\u2013485 (2020).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"901_CR168","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0272-6386(12)80813-4","volume":"23","author":"SH Hou","year":"1994","unstructured":"Hou, S. H. Frequency and outcome of pregnancy in women on dialysis. Am. J. Kidney Dis. 23, 60\u201363 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"901_CR169","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0272-6386(98)70060-5","volume":"31","author":"JA Bagon","year":"1998","unstructured":"Bagon, J. A. et al. Pregnancy and dialysis. Am. J. Kidney Dis. 31, 756 (1998).","journal-title":"Am. J. Kidney Dis."},{"key":"901_CR170","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11255-008-9475-z","volume":"41","author":"EK Basok","year":"2009","unstructured":"Basok, E. K. et al. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients. Int. Urol. Nephrol. 41, 473\u2013481 (2009).","journal-title":"Int. Urol. Nephrol."},{"key":"901_CR171","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1093\/ndt\/gfh279","volume":"19","author":"J Matuszkiewicz-Rowinska","year":"2004","unstructured":"Matuszkiewicz-Rowinska, J. et al. Endometrial morphology and pituitary-gonadal axis dysfunction in women of reproductive age undergoing chronic haemodialysis \u2014 a multicentre study. Nephrol. Dial. Transpl. 19, 2074\u20132077 (2004).","journal-title":"Nephrol. Dial. Transpl."},{"key":"901_CR172","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/PGP.0b013e3181671aad","volume":"27","author":"EM Hosfield","year":"2008","unstructured":"Hosfield, E. M., Rabban, J. T., Chen, L. M. & Zaloudek, C. J. Squamous metaplasia of the ovarian surface epithelium and subsurface fibrosis: distinctive pathologic findings in the ovaries and fallopian tubes of patients on peritoneal dialysis. Int. J. Gynecol. Pathol. 27, 465\u2013474 (2008).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"901_CR173","first-page":"74","volume":"8","author":"P Confortini","year":"1971","unstructured":"Confortini, P. et al. Full term successful pregnancy and successful delivery in a patient on chronic haemodialysis. Proc. Eur. Dial. Transpl. Assoc. 8, 74\u201380 (1971).","journal-title":"Proc. Eur. Dial. Transpl. Assoc."},{"key":"901_CR174","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1093\/ndt\/gfv395","volume":"31","author":"GB Piccoli","year":"2016","unstructured":"Piccoli, G. B. et al. Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes. Nephrol. Dial. Transplant. 31, 1915\u20131934 (2016).","journal-title":"Nephrol. Dial. Transplant."},{"key":"901_CR175","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/ckj\/sfac204","volume":"16","author":"H Baouche","year":"2023","unstructured":"Baouche, H. et al. Pregnancy in women on chronic dialysis in the last decade (2010\u20132020): a systematic review. Clin. Kidney J. 16, 138\u2013150 (2023).","journal-title":"Clin. Kidney J."},{"key":"901_CR176","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1681\/ASN.2013080825","volume":"25","author":"MA Hladunewich","year":"2014","unstructured":"Hladunewich, M. A. et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J. Am. Soc. Nephrol. 25, 1103\u20131109 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"901_CR177","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.ekir.2018.04.013","volume":"3","author":"C Luders","year":"2018","unstructured":"Luders, C., Titan, S. M., Kahhale, S., Francisco, R. P. & Zugaib, M. Risk factors for adverse fetal outcome in hemodialysis pregnant women. Kidney Int. Rep. 3, 1077\u20131088 (2018).","journal-title":"Kidney Int. Rep."},{"key":"901_CR178","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2215\/CJN.06170612","volume":"8","author":"K Bramham","year":"2013","unstructured":"Bramham, K. et al. Pregnancy in renal transplant recipients: a UK national cohort study. Clin. J. Am. Soc. Nephrol. 8, 290\u2013298 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"901_CR179","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet 398, 341\u2013354 (2021).","journal-title":"Lancet"},{"key":"901_CR180","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/uog.19112","volume":"52","author":"MY Tan","year":"2018","unstructured":"Tan, M. Y. et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation. Ultrasound Obstet. Gynecol. 52, 186\u2013195 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"901_CR181","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","volume":"128","author":"LC Chappell","year":"2013","unstructured":"Chappell, L. C. et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 128, 2121\u20132131 (2013).","journal-title":"Circulation"},{"key":"901_CR182","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","volume":"393","author":"KE Duhig","year":"2019","unstructured":"Duhig, K. E. et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet 393, 1807\u20131818 (2019).","journal-title":"Lancet"},{"key":"901_CR183","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","volume":"74","author":"AS Cerdeira","year":"2019","unstructured":"Cerdeira, A. S. et al. Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia: INSPIRE. Hypertension 74, 983\u2013990 (2019).","journal-title":"Hypertension"},{"key":"901_CR184","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.preghy.2021.02.010","volume":"24","author":"K Wiles","year":"2021","unstructured":"Wiles, K. et al. Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease. Pregnancy Hypertens. 24, 58\u201364 (2021).","journal-title":"Pregnancy Hypertens."},{"key":"901_CR185","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.preghy.2018.02.007","volume":"12","author":"M Gupta","year":"2018","unstructured":"Gupta, M., Feinberg, B. B. & Burwick, R. M. Thrombotic microangiopathies of pregnancy: differential diagnosis. Pregnancy Hypertens. 12, 29\u201334 (2018).","journal-title":"Pregnancy Hypertens."},{"key":"901_CR186","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/jcm12051834","volume":"12","author":"G Moroni","year":"2023","unstructured":"Moroni, G., Calatroni, M., Donato, B. & Ponticelli, C. Kidney biopsy in pregnant women with glomerular diseases: focus on lupus nephritis. J. Clin. Med. 12, 1834 (2023).","journal-title":"J. Clin. Med."},{"key":"901_CR187","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/jama.2018.17948","volume":"321","author":"Z Harel","year":"2019","unstructured":"Harel, Z. et al. Serum creatinine levels before, during, and after pregnancy. JAMA 321, 205\u2013207 (2019).","journal-title":"JAMA"},{"key":"901_CR188","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5301\/jn.5000013","volume":"25","author":"Machado S","year":"2012","unstructured":"Machado S et al. Acute kidney injury in pregnancy: a clinical challenge. J. Nephrol. 25, 19\u201330 (2012).","journal-title":"J. Nephrol."},{"key":"901_CR189","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ekir.2018.10.015","volume":"4","author":"K Wiles","year":"2018","unstructured":"Wiles, K. et al. Serum creatinine in pregnancy: a systematic review. Kidney Int. Rep. 4, 408\u2013419 (2018).","journal-title":"Kidney Int. Rep."},{"key":"901_CR190","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/ndt\/gfaa217","volume":"36","author":"RM Gama","year":"2021","unstructured":"Gama, R. M. et al. Acute kidney injury e-alerts in pregnancy: rates, recognition and recovery. Nephrol. Dial. Transpl. 36, 1023\u20131030 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"901_CR191","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1161\/HYPERTENSIONAHA.119.13089","volume":"74","author":"FI Conti-Ramsden","year":"2019","unstructured":"Conti-Ramsden, F. I. et al. Pregnancy-related acute kidney injury in preeclampsia: risk factors and renal outcomes. Hypertension 74, 1144\u20131151 (2019).","journal-title":"Hypertension"},{"key":"901_CR192","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2215\/CJN.10410919","volume":"15","author":"RA Noble","year":"2020","unstructured":"Noble, R. A., Lucas, B. J. & Selby, N. M. Long-term outcomes in patients with acute kidney injury. Clin. J. Am. Soc. Nephrol. 15, 423\u2013429 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"901_CR193","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3892\/etm.2021.10949","volume":"23","author":"E Ciciu","year":"2022","unstructured":"Ciciu, E., Pa\u1e63atu-Cornea, A. M., Petcu, L. C. & Tu\u0163\u0103, L. A. Early diagnosis and management of maternal ureterohydronephrosis during pregnancy. Exp. Ther. Med. 23, 27 (2022).","journal-title":"Exp. Ther. Med."},{"key":"901_CR194","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S0022-5347(17)36821-0","volume":"148","author":"JD Denstedt","year":"1992","unstructured":"Denstedt, J. D. & Razvi, H. Management of urinary calculi during pregnancy. J. Urol. 148, 1072\u20131074 (1992).","journal-title":"J. Urol."},{"key":"901_CR195","first-page":"E676","volume":"15","author":"JY Lee","year":"2021","unstructured":"Lee, J. Y. et al. Canadian Urological Association guideline: management of ureteral calculi \u2014 full-text. Can. Urol. Assoc. J. 15, E676\u2013E690 (2021).","journal-title":"Can. Urol. Assoc. J."},{"key":"901_CR196","doi-asserted-by":"publisher","first-page":"S435","DOI":"10.1016\/j.ekir.2024.02.911","volume":"9","author":"K Clark","year":"2024","unstructured":"Clark, K. et al. WCN24-1183 Assessing kidney function in pregnancy: gestation specific centile reference ranges for serum creatinine, urea, cystatin c and beta-2-microglobulin. Kidney Int. Rep. 9, S435\u2013S436 (2024).","journal-title":"Kidney Int. Rep."},{"key":"901_CR197","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1053\/j.ajkd.2020.01.007","volume":"76","author":"CD Chu","year":"2020","unstructured":"Chu, C. D. et al. CKD awareness among US adults by future risk of kidney failure. Am. J. Kidney Dis. 76, 174\u2013183 (2020).","journal-title":"Am. J. Kidney Dis."},{"key":"901_CR198","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/ndt\/gfac051","volume":"38","author":"GB Piccoli","year":"2023","unstructured":"Piccoli, G. B. et al. Adding creatinine to routine pregnancy tests: a decision tree for calculating the cost of identifying patients with CKD in pregnancy. Nephrol. Dial. Transpl. 38, 148\u2013157 (2023).","journal-title":"Nephrol. Dial. Transpl."},{"key":"901_CR199","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-032300","volume":"148","author":"C Crump","year":"2021","unstructured":"Crump, C., Sundquist, J. & Sundquist, K. Preterm or early term birth and risk of autism. Pediatrics 148, e2020032300 (2021).","journal-title":"Pediatrics"},{"key":"901_CR200","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006696","volume":"96","author":"C Wang","year":"2017","unstructured":"Wang, C., Geng, H., Liu, W. & Zhang, G. Prenatal, perinatal, and postnatal factors associated with autism: a meta-analysis. Medicine 96, e6696 (2017).","journal-title":"Medicine"},{"key":"901_CR201","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrneph.2017.187","volume":"14","author":"KS Wiles","year":"2018","unstructured":"Wiles, K. S., Nelson-Piercy, C. & Bramham, K. Reproductive health and pregnancy in women with chronic kidney disease. Nat. Rev. Nephrol. 14, 165\u2013184 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"901_CR202","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1007\/s00246-015-1182-9","volume":"36","author":"A Ramakrishnan","year":"2015","unstructured":"Ramakrishnan, A., Lee, L. J., Mitchell, L. E. & Agopian, A. J. Maternal hypertension during pregnancy and the risk of congenital heart defects in offspring: a systematic review and meta-analysis. Pediatr. Cardiol. 36, 1442 (2015).","journal-title":"Pediatr. Cardiol."},{"key":"901_CR203","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/1471-0528.13138","volume":"122","author":"MMHJ van Gelder","year":"2015","unstructured":"van Gelder, M. M. H. J. et al. Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study. BJOG 122, 1002\u20131009 (2015).","journal-title":"BJOG"},{"key":"901_CR204","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1404595","volume":"372","author":"LA Magee","year":"2015","unstructured":"Magee, L. A. et al. Less-tight versus tight control of hypertension in pregnancy. N. Engl. J. Med. 372, 407\u2013417 (2015).","journal-title":"N. Engl. J. Med."},{"key":"901_CR205","unstructured":"At, T. et al. Treatment for mild chronic hypertension during pregnancy. N. Engl. J. Med. 386, 1781\u20131792."},{"key":"901_CR206","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1113\/EP089918","volume":"107","author":"VA Luyckx","year":"2022","unstructured":"Luyckx, V. A. & Chevalier, R. L. Impact of early life development on later onset chronic kidney disease and hypertension and the role of evolutionary trade-offs. Exp. Physiol. 107, 410\u2013414 (2022).","journal-title":"Exp. Physiol."},{"key":"901_CR207","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1046\/j.1523-1755.2003.00018.x","volume":"63","author":"M Hughson","year":"2003","unstructured":"Hughson, M., Farris, A. B., Douglas-Denton, R., Hoy, W. E. & Bertram, J. F. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 63, 2113\u20132122 (2003).","journal-title":"Kidney Int."},{"key":"901_CR208","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41581-022-00668-8","volume":"19","author":"MR Sutherland","year":"2023","unstructured":"Sutherland, M. R. & Black, M. J. The impact of intrauterine growth restriction and prematurity on nephron endowment. Nat. Rev. Nephrol. 19, 218\u2013228 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"901_CR209","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0378-3782(83)90016-6","volume":"8","author":"BS Stonestreet","year":"1983","unstructured":"Stonestreet, B. S., Hansen, N. B., Laptook, A. R. & Oh, W. Glucocorticoid accelerates renal functional maturation in fetal lambs. Early Hum. Dev. 8, 331\u2013341 (1983).","journal-title":"Early Hum. Dev."},{"key":"901_CR210","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1161\/01.CIR.103.9.1264","volume":"103","author":"CPM Leeson","year":"2001","unstructured":"Leeson, C. P. M., Kattenhorn, M., Morley, R., Lucas, A. & Deanfield, J. E. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 103, 1264\u20131268 (2001).","journal-title":"Circulation"},{"key":"901_CR211","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00489-y","volume":"11","author":"A Cwiek","year":"2021","unstructured":"Cwiek, A. et al. Premature differentiation of nephron progenitor cell and dysregulation of gene pathways critical to kidney development in a model of preterm birth. Sci. Rep. 11, 21667 (2021).","journal-title":"Sci. Rep."},{"key":"901_CR212","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41588-019-0403-1","volume":"51","author":"NM Warrington","year":"2019","unstructured":"Warrington, N. M. et al. Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors. Nat. Genet. 51, 804\u2013814 (2019).","journal-title":"Nat. Genet."},{"key":"901_CR213","doi-asserted-by":"publisher","first-page":"769734","DOI":"10.3389\/fmed.2021.769734","volume":"8","author":"MA Grillo","year":"2021","unstructured":"Grillo, M. A., Mariani, G. & Ferraris, J. R. Prematurity and low birth weight in neonates as a risk factor for obesity, hypertension, and chronic kidney disease in pediatric and adult age. Front. Med. 8, 769734 (2021).","journal-title":"Front. Med."},{"key":"901_CR214","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071465","volume":"8","author":"TW Kelsey","year":"2013","unstructured":"Kelsey, T. W. et al. Ovarian volume throughout life: a validated normative model. PLoS ONE 8, e71465 (2013).","journal-title":"PLoS ONE"},{"key":"901_CR215","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1530\/rep.0.1250769","volume":"125","author":"RM Sharpe","year":"2003","unstructured":"Sharpe, R. M., McKinnell, C., Kivlin, C. & Fisher, J. S. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reprod. Camb. Engl. 125, 769\u2013784 (2003).","journal-title":"Reprod. Camb. Engl."},{"key":"901_CR216","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0890-6238(92)90192-V","volume":"6","author":"JM Ratcliffe","year":"1992","unstructured":"Ratcliffe, J. M., Gladen, B. C., Wilcox, A. J. & Herbst, A. L. Does early exposure to maternal smoking affect future fertility in adult males? Reprod. Toxicol. Elmsford N. 6, 297\u2013307 (1992).","journal-title":"Reprod. Toxicol. Elmsford N."},{"key":"901_CR217","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/oxfordjournals.aje.a009576","volume":"148","author":"TK Jensen","year":"1998","unstructured":"Jensen, T. K. et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am. J. Epidemiol. 148, 992\u2013997 (1998).","journal-title":"Am. J. Epidemiol."},{"key":"901_CR218","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.EDE.0000059922.73864.3E","volume":"14","author":"L Storgaard","year":"2003","unstructured":"Storgaard, L. et al. Does smoking during pregnancy affect sons\u2019 sperm counts? Epidemiol. Camb. Mass. 14, 278\u2013286 (2003).","journal-title":"Epidemiol. Camb. Mass."},{"key":"901_CR219","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/aje\/kwh002","volume":"159","author":"TK Jensen","year":"2004","unstructured":"Jensen, T. K. et al. Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries. Am. J. Epidemiol. 159, 49\u201358 (2004).","journal-title":"Am. J. Epidemiol."},{"key":"901_CR220","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrendo.2014.97","volume":"10","author":"A Juul","year":"2014","unstructured":"Juul, A. et al. Possible fetal determinants of male infertility. Nat. Rev. Endocrinol. 10, 553\u2013562 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"901_CR221","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(10)60236-X","volume":"375","author":"F Hildebrandt","year":"2010","unstructured":"Hildebrandt, F. Genetic kidney diseases. Lancet 375, 1287\u20131295 (2010).","journal-title":"Lancet"},{"key":"901_CR222","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/ckj\/sfab056","volume":"14","author":"R Torra","year":"2021","unstructured":"Torra, R., Furlano, M., Ortiz, A. & Ars, E. Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports. Clin. Kidney J. 14, 1879\u20131885 (2021).","journal-title":"Clin. Kidney J."},{"key":"901_CR223","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000436983","volume":"130","author":"DM Connaughton","year":"2015","unstructured":"Connaughton, D. M. et al. The Irish kidney gene project \u2014 prevalence of family history in patients with kidney disease in Ireland. Nephron 130, 293\u2013301 (2015).","journal-title":"Nephron"},{"key":"901_CR224","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejogrb.2020.01.034","volume":"246","author":"S Thakoordeen-Reddy","year":"2020","unstructured":"Thakoordeen-Reddy, S. et al. Maternal variants within the apolipoprotein L1 gene are associated with preeclampsia in a South African cohort of African ancestry. Eur. J. Obstet. Gynecol. Reprod. Biol. 246, 129\u2013133 (2020).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"901_CR225","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ajhg.2018.08.002","volume":"103","author":"KJ Reidy","year":"2018","unstructured":"Reidy, K. J. et al. Fetal \u2014 not maternal \u2014 APOL1 genotype associated with risk for preeclampsia in those with African ancestry. Am. J. Hum. Genet. 103, 367\u2013376 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"901_CR226","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1681\/ASN.2014111131","volume":"27","author":"MG Sampson","year":"2016","unstructured":"Sampson, M. G. et al. Integrative genomics identifies novel associations with APOL1 risk genotypes in Black Neptune subjects. J. Am. Soc. Nephrol. 27, 814\u2013823 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"901_CR227","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1053\/j.ajkd.2018.06.025","volume":"72","author":"M Moxey-Mims","year":"2018","unstructured":"Moxey-Mims, M. Kidney disease in African American children: biological and nonbiological disparities. Am. J. Kidney Dis. 72, S17\u2013S21 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"901_CR228","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1055\/s-0035-1556743","volume":"4","author":"LA Coscia","year":"2015","unstructured":"Coscia, L. A. et al. Update on the teratogenicity of maternal mycophenolate mofetil. J. Pediatr. Genet. 4, 42\u201355 (2015).","journal-title":"J. Pediatr. Genet."},{"key":"901_CR229","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/1744666X.2019.1561282","volume":"15","author":"A Pham-Huy","year":"2019","unstructured":"Pham-Huy, A. et al. From mother to baby: antenatal exposure to monoclonal antibody biologics. Expert. Rev. Clin. Immunol. 15, 221\u2013229 (2019).","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"901_CR230","doi-asserted-by":"publisher","unstructured":"Committee on Infectious Diseases AA of P, Kimberlin, D. W., Barnett, E. D., Lynfield, R., Sawyer, M. H. (eds). Immunization in Special Clinical Circumstances. In: Red Book: 2021\u20132024 Report of the Committee on Infectious Diseases [Internet]. American Academy of Pediatrics, (2021) [cited 2024 Oct 22]. p. 0. Available from: https:\/\/doi.org\/10.1542\/9781610025782.","DOI":"10.1542\/9781610025782"},{"key":"901_CR231","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.imbio.2014.11.003","volume":"220","author":"RF Hallstensen","year":"2015","unstructured":"Hallstensen, R. F. et al. Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn. Immunobiology 220, 452\u2013459 (2015).","journal-title":"Immunobiology"},{"key":"901_CR232","first-page":"CD003517","volume":"2012","author":"MS Kramer","year":"2012","unstructured":"Kramer, M. S. & Kakuma, R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst. Rev. 2012, CD003517 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"901_CR233","unstructured":"Kramer M. S. & Kakuma R. in Protecting Infants through Human Milk. (eds Pickering L. K., Morrow A. L., Ruiz-Palacios G. M. & Schanler R.J.) Advances in Experimental Medicine and Biology. 63\u201377 (Springer, 2004)."},{"key":"901_CR234","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1001\/jama.294.20.2601","volume":"294","author":"AM Stuebe","year":"2005","unstructured":"Stuebe, A. M., Rich-Edwards, J. W., Willett, W. C., Manson, J. E. & Michels, K. B. Duration of lactation and incidence of type 2 diabetes. JAMA 294, 2601\u20132610 (2005).","journal-title":"JAMA"},{"key":"901_CR235","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/jnnp-2022-329545","volume":"94","author":"BE R\u00f8d","year":"2023","unstructured":"R\u00f8d, B. E., Torkildsen, \u00d8., Myhr, K.-M., B\u00f8, L. & Wergeland, S. Safety of breast feeding during rituximab treatment in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 94, 38 (2023).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"901_CR236","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/jcm8030407","volume":"8","author":"V Stefanovic","year":"2019","unstructured":"Stefanovic, V. The extended use of eculizumab in pregnancy and complement activation\u2212associated diseases affecting maternal, fetal and neonatal kidneys \u2014 the future is now? J. Clin. Med. 8, 407 (2019).","journal-title":"J. Clin. Med."},{"key":"901_CR237","unstructured":"APILAM. [cited 2024 May 30]. http:\/\/e-lactancia.org\/privacidad\/."},{"key":"901_CR238","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.fertnstert.2015.11.011","volume":"105","author":"ML Eisenberg","year":"2016","unstructured":"Eisenberg, M. L., Li, S., Cullen, M. R. & Baker, L. C. Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data. Fertil. Steril. 105, 629\u2013636 (2016).","journal-title":"Fertil. Steril."},{"key":"901_CR239","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58479-9","volume":"14","author":"M Kitlinski","year":"2024","unstructured":"Kitlinski, M., Giwercman, A., Christensson, A., Nilsson, P. M. & Elenkov, A. Prevalence of impaired renal function among childless men as compared to fathers: a population-based study. Sci. Rep. 14, 7720 (2024).","journal-title":"Sci. Rep."},{"key":"901_CR240","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1053\/j.ajkd.2007.03.022","volume":"49","author":"E Imbasciati","year":"2007","unstructured":"Imbasciati, E. et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am. J. Kidney Dis. 49, 753\u2013762 (2007).","journal-title":"Am. J. Kidney Dis."},{"key":"901_CR241","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1590\/2175-8239-jbn-2020-0055","volume":"43","author":"IF Gouveia","year":"2021","unstructured":"Gouveia, I. F., Silva, J. R., Santos, C. & Carvalho, C. Maternal and fetal outcomes of pregnancy in chronic kidney disease: diagnostic challenges, surveillance and treatment throughout the spectrum of kidney disease. J. Bras. Nefrol. 43, 88\u2013102 (2021).","journal-title":"J. Bras. Nefrol."},{"key":"901_CR242","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.semnephrol.2017.05.009","volume":"37","author":"K Bramham","year":"2017","unstructured":"Bramham, K. Pregnancy in renal transplant recipients and donors. Semin. Nephrol. 37, 370\u2013377 (2017).","journal-title":"Semin. Nephrol."},{"key":"901_CR243","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4081\/pr.2010.e7","volume":"2","author":"I Banerjee","year":"2010","unstructured":"Banerjee, I. et al. Health outcomes of children born to mothers with chronic kidney disease: a pilot study. Pediatr. Rep. 2, 22\u201325 (2010).","journal-title":"Pediatr. Rep."},{"key":"901_CR244","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1093\/ndt\/gfr617","volume":"27","author":"P Abou-Jaoude","year":"2012","unstructured":"Abou-Jaoude, P. et al. What about the renal function during childhood of children born from dialysed mothers? Nephrol. Dial. Transpl. 27, 2365\u20132369 (2012).","journal-title":"Nephrol. Dial. Transpl."},{"key":"901_CR245","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/j.ackd.2007.01.014","volume":"14","author":"DL Blowey","year":"2007","unstructured":"Blowey, D. L. & Warady, B. A. Outcome of infants born to women with chronic kidney disease. Adv. Chronic Kidney Dis. 14, 199\u2013205 (2007).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"901_CR246","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1053\/j.ajkd.2015.08.023","volume":"66","author":"A Tong","year":"2015","unstructured":"Tong, A., Brown, M. A., Winkelmayer, W. C., Craig, J. C. & Jesudason, S. Perspectives on pregnancy in women with CKD: a semistructured interview study. Am. J. Kidney Dis. 66, 951\u2013961 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"901_CR247","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254956","volume":"16","author":"ER Ralston","year":"2021","unstructured":"Ralston, E. R., Smith, P., Chilcot, J., Silverio, S. A. & Bramham, K. Perceptions of risk in pregnancy with chronic disease: a systematic review and thematic synthesis. PLoS ONE 16, e0254956 (2021).","journal-title":"PLoS ONE"},{"key":"901_CR248","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1469-8749.2012.04348.x","volume":"54","author":"AL Scherzer","year":"2012","unstructured":"Scherzer, A. L., Chhagan, M., Kauchali, S. & Susser, E. Global perspective on early diagnosis and intervention for children with developmental delays and disabilities. Dev. Med. Child. Neurol. 54, 1079\u20131084 (2012).","journal-title":"Dev. Med. Child. Neurol."},{"key":"901_CR249","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0731","volume":"138","author":"BT Bateman","year":"2016","unstructured":"Bateman, B. T. et al. Late pregnancy \u03b2 blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics 138, e20160731 (2016).","journal-title":"Pediatrics"},{"key":"901_CR250","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preghy.2018.01.002","volume":"11","author":"JL Morgan","year":"2018","unstructured":"Morgan, J. L. et al. Pharmacokinetics of amlodipine besylate at delivery and during lactation. Pregnancy Hypertens. 11, 77\u201380 (2018).","journal-title":"Pregnancy Hypertens."},{"key":"901_CR251","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/1471-0528.12678","volume":"121","author":"RH Xie","year":"2014","unstructured":"Xie, R. H. et al. Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy. BJOG 121, 1090\u20131096 (2014).","journal-title":"BJOG"},{"key":"901_CR252","first-page":"CD002863","volume":"2003","author":"LA Magee","year":"2000","unstructured":"Magee L. A., Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst. Rev. 2003, CD002863 (2000).","journal-title":"Cochrane Database Syst. Rev."},{"key":"901_CR253","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1331\/JAPhA.2012.10139","volume":"52","author":"FJ Nice","year":"2012","unstructured":"Nice, F. J. & Luo, A. C. Medications and breast-feeding: current concepts. J. Am. Pharm. Assoc. 52, 86\u201394 (2012).","journal-title":"J. Am. Pharm. Assoc."},{"key":"901_CR254","unstructured":"National Collaborating Centre for Women\u2019s and Children\u2019s Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy (RCOG Press, 2010)."},{"key":"901_CR255","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11095-017-2323-z","volume":"35","author":"A Ornoy","year":"2018","unstructured":"Ornoy, A. Pharmacological treatment of attention deficit hyperactivity disorder during pregnancy and lactation. Pharm. Res. 35, 46 (2018).","journal-title":"Pharm. Res."},{"key":"901_CR256","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1093\/rheumatology\/keac552","volume":"62","author":"K Schreiber","year":"2023","unstructured":"Schreiber, K. et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice. Rheumatology 62, e89\u2013e104 (2023).","journal-title":"Rheumatology"},{"key":"901_CR257","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1471-0528.2006.01232.x","volume":"114","author":"A Sau","year":"2007","unstructured":"Sau, A. et al. Azathioprine and breastfeeding: is it safe? BJOG 114, 498\u2013501 (2007).","journal-title":"BJOG"},{"key":"901_CR258","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2215\/CJN.06400612","volume":"8","author":"K Bramham","year":"2013","unstructured":"Bramham, K., Chusney, G., Lee, J., Lightstone, L. & Nelson-Piercy, C. Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. Clin. J. Am. Soc. Nephrol. 8, 563 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"901_CR259","doi-asserted-by":"crossref","unstructured":"Muller, D. R. P. et al. Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence. Front. Endocrinol. 14 (2023).","DOI":"10.3389\/fendo.2023.1215356"},{"key":"901_CR260","unstructured":"World Health Organization. Breastfeeding and maternal medication: recommendations for drugs in the eleventh WHO model list of essential drugs. https:\/\/iris.who.int\/handle\/10665\/62435 (2002)."},{"key":"901_CR261","first-page":"938","volume":"95","author":"SL Clark","year":"2000","unstructured":"Clark, S. L., Porter, T. F. & West, F. G. Coumarin derivatives and breast-feeding. Obstet. Gynecol. 95, 938\u2013940 (2000).","journal-title":"Obstet. Gynecol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-024-00901-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-024-00901-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-024-00901-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T13:03:23Z","timestamp":1737551003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-024-00901-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":261,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["901"],"URL":"https:\/\/doi.org\/10.1038\/s41581-024-00901-6","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"30 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}